Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors by Camilla Nero, Francesca Ciccarone, Antonella Pietragalla, Simona Duranti, Gennaro Daniele, Vanda Salutari, Maria Vittoria Carbone, Giovanni Scambia, Domenica Lorusso

“…Ovarian cancer treatment strategy is mainly based on three pillars: cytoreductive surgery, platinum-based chemotherapy, and targeted therapies. …”
Get full text

Transcriptional regulation of cancer stem cell: regulatory factors elucidation and cancer treatment strategies by Zhengyue Zhang, Yanjie Zhang

Get full text

Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment (2022) by I. E. Chazova, F. T. Ageev, A. V. Aksenova, M. V. Vicenya, M. Yu. Gilyarov, T. V. Martynyuk, E. P. Panchenko, M. G. Poltavskaya, V. I. Potievskaya, O. P. Trofimova, Yu. A. Fedotkina

Get full text

Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment? by Seul-Ki Choi, Heejin Kam, Kye-Young Kim, Suk In Park, Yun-Sil Lee

Get full text

Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment by Bo Deng, Bing Ma, Yingying Ma, Pei Cao, Xigang Leng, Pengyu Huang, Yuanyuan Zhao, Tianjiao Ji, Xueguang Lu, Lanxia Liu

Get full text

Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications by Dinh-Toi Chu, Tiep Tien Nguyen, Nguyen Le Bao Tien, Dang-Khoa Tran, Jee-Heon Jeong, Pham Gia Anh, Vo Van Thanh, Dang Tien Truong, Thien Chu Dinh

Subjects: Get full text

Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment by Rafaela Rodrigues, Diana Duarte, Nuno Vale

“…Although the scientific community has been concerned about guaranteeing the quality of life of cancer patients, researchers are also aware of the increasing costs related to cancer treatment, and efforts have been made to find alternatives to the development of new drugs. …”
Get full text

Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment by Azadeh Hekmat, Luciano Saso, Viney Lather, Deepti Pandita, Irena Kostova, Ali Akbar Saboury

“…In this review, the data available on nanomaterials of group XIV for breast cancer treatment has been documented, providing a useful insight into tumor biology and nano–bio interactions to develop more effective nanotherapeutics for cancer patients.…”
Get full text

The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review by Elena Ferrari, Saverio Bettuzzi, Valeria Naponelli

“…Autophagy represents a promising but challenging target in cancer treatment. Green tea is a widely used beverage with healthy effects on several diseases, including cancer. …”
Get full text

Corrigendum: Landscape of pediatric cancer treatment refusal and abandonment in the US: a qualitative study by Daniel J. Benedetti, Daniel J. Benedetti, Catherine M. Hammack-Aviran, Carolyn Diehl, Laura M. Beskow

Get full text

A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment by Jlenia Brunetti, Sara Piantini, Marco Fragai, Silvia Scali, Giulia Cipriani, Lorenzo Depau, Alessandro Pini, Chiara Falciani, Stefano Menichetti, Luisa Bracci

Get full text

Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib by Cyril Sobolewski, Noémie Legrand

“…In this review, we discuss the impact of these two analogues on cancerous processes but also their potential for cancer treatment alone or in combination with existing approaches.…”
Get full text

Investigating the effect of herbal antioxidants on the process of colon cancer treatment: A systematic review by Naser Mohammad gholi Mezerji, Abbas Moghimbeigi, Mostafa Eghbalian, Mahmoud Rafieian Kopaei

Get full text

Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment by Sze‐Ching Wong, Chun‐Chieh Yeh, Xun‐Yu Zhang, Chih‐Ying Hsieh, Chia‐Chien Lo, Ting‐Ting Kuo, Ching‐Chan Lin, Chih‐Hua Chao, Jing‐Pei Liu, Ling‐Chu Chang, Lu‐Hai Wang, Yuh‐Pyng Sher

“…CUB domain‐containing protein 1 (CDCP1) contributes to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistance by regulating EGFR signaling pathways and is a potential target in lung cancer treatment. This study aims to identify a CDCP1 reducer that synergistically improves TKI treatment. …”
Get full text

Advancing Ovarian Cancer Treatment: The Latest Insights on PARP Inhibitors from ASCO 2023 by Yves van Roon, Marcus Vetter

Get full text

Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation by Mohammad Chehelgerdi, Matin Chehelgerdi, Omer Qutaiba B. Allela, Renzon Daniel Cosme Pecho, Narayanan Jayasankar, Devendra Pratap Rao, Tamilanban Thamaraikani, Manimaran Vasanthan, Patrik Viktor, Natrayan Lakshmaiya, Mohamed J. Saadh, Ayesha Amajd, Mabrouk A. Abo-Zaid, Roxana Yolanda Castillo-Acobo, Ahmed H. Ismail, Ali H. Amin, Reza Akhavan-Sigari

Subjects: Get full text

Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment by Ruma Rani, Parth Malik, Sunena Dhania, Tapan Kumar Mukherjee

Get full text

A review of the pharmacodynamic effect of chemo-herbal drug combinations therapy for cancer treatment by Ambrose Okem, Charlotte Henstra, Maarten Lambert, Rose Hayeshi

Get full text

Potential of <i>Kalanchoe pinnata</i> as a Cancer Treatment Adjuvant and an Epigenetic Regulator by Marta Elena Hernández-Caballero, José Alfredo Sierra-Ramírez, Ricardo Villalobos-Valencia, Emmanuel Seseña-Méndez

“…All of the data support the use of <i>K. pinnata</i> as an adjuvant in cancer treatment.…”
Get full text

Preparation and Characterisation of Zinc Diethyldithiocarbamate–Cyclodextrin Inclusion Complexes for Potential Lung Cancer Treatment by Ayşe Kaya, Basel Arafat, Havovi Chichger, Ibrahim Tolaymat, Barbara Pierscionek, Mouhamad Khoder, Mohammad Najlah

Get full text